Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including g...

Descripción completa

Detalles Bibliográficos
Autores principales: Moors, Tim E., Hoozemans, Jeroen J. M., Ingrassia, Angela, Beccari, Tommaso, Parnetti, Lucilla, Chartier-Harlin, Marie-Christine, van de Berg, Wilma D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267440/
https://www.ncbi.nlm.nih.gov/pubmed/28122627
http://dx.doi.org/10.1186/s13024-017-0154-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267440/
https://www.ncbi.nlm.nih.gov/pubmed/28122627
http://dx.doi.org/10.1186/s13024-017-0154-3

Ejemplares similares